1. Home
  2. BLCO vs PAY Comparison

BLCO vs PAY Comparison

Compare BLCO & PAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • PAY
  • Stock Information
  • Founded
  • BLCO 1853
  • PAY 2004
  • Country
  • BLCO Canada
  • PAY United States
  • Employees
  • BLCO N/A
  • PAY N/A
  • Industry
  • BLCO Ophthalmic Goods
  • PAY Computer Software: Prepackaged Software
  • Sector
  • BLCO Health Care
  • PAY Technology
  • Exchange
  • BLCO Nasdaq
  • PAY Nasdaq
  • Market Cap
  • BLCO 4.0B
  • PAY 3.4B
  • IPO Year
  • BLCO 2022
  • PAY 2021
  • Fundamental
  • Price
  • BLCO $11.87
  • PAY $29.08
  • Analyst Decision
  • BLCO Hold
  • PAY Hold
  • Analyst Count
  • BLCO 12
  • PAY 6
  • Target Price
  • BLCO $18.64
  • PAY $30.83
  • AVG Volume (30 Days)
  • BLCO 906.7K
  • PAY 437.7K
  • Earning Date
  • BLCO 04-30-2025
  • PAY 05-05-2025
  • Dividend Yield
  • BLCO N/A
  • PAY N/A
  • EPS Growth
  • BLCO N/A
  • PAY 94.45
  • EPS
  • BLCO N/A
  • PAY 0.35
  • Revenue
  • BLCO $4,791,000,000.00
  • PAY $871,745,000.00
  • Revenue This Year
  • BLCO $6.43
  • PAY $24.69
  • Revenue Next Year
  • BLCO $5.59
  • PAY $19.69
  • P/E Ratio
  • BLCO N/A
  • PAY $82.37
  • Revenue Growth
  • BLCO 15.56
  • PAY 41.87
  • 52 Week Low
  • BLCO $10.46
  • PAY $16.94
  • 52 Week High
  • BLCO $21.69
  • PAY $38.94
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 36.46
  • PAY 57.80
  • Support Level
  • BLCO $10.46
  • PAY $23.88
  • Resistance Level
  • BLCO $12.38
  • PAY $30.19
  • Average True Range (ATR)
  • BLCO 0.92
  • PAY 1.62
  • MACD
  • BLCO -0.09
  • PAY 0.51
  • Stochastic Oscillator
  • BLCO 33.02
  • PAY 91.45

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About PAY Paymentus Holdings Inc.

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.

Share on Social Networks: